We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCGN icon
2101
Ocugen
OCGN
$458M
$17.6K ﹤0.01%
7,770
-4,350
-36% -$10.4K
SENS icon
2102
Senseonics Holdings Inc
SENS
$409M
$17.6K ﹤0.01%
856
-536
-39% -$14K
TIL icon
2103
Instil Bio
TIL
$49.3M
$17.6K ﹤0.01%
190
STOK icon
2104
Stoke Therapeutics
STOK
$2.02B
$17.5K ﹤0.01%
1,325
SPFI icon
2105
South Plains Financial
SPFI
$859M
$17.5K ﹤0.01%
725
BATRA icon
2106
Atlanta Braves Holdings Series A
BATRA
$3.64B
$17.4K ﹤0.01%
693
BFLY icon
2107
Butterfly Network
BFLY
$2.36B
$17.4K ﹤0.01%
5,676
-3,157
-36% -$10.9K
ENFN
2108
DELISTED
Enfusion, Inc.
ENFN
$17.4K ﹤0.01%
1,706
JMSB icon
2109
John Marshall Bancorp
JMSB
$328M
$17.4K ﹤0.01%
+771
New +$20K
AGEN
2110
Agenus
AGEN
$315M
$17.3K ﹤0.01%
455
-285
-39% -$10.3K
BTAI icon
2111
BioXcel Therapeutics
BTAI
$34.9M
$17.2K ﹤0.01%
82
NRGV icon
2112
Energy Vault
NRGV
$669M
$17.2K ﹤0.01%
+1,719
New +$22.3K
HYZN
2113
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$17.2K ﹤0.01%
+117
New +$24.8K
HYLN icon
2114
Hyliion Holdings
HYLN
$734M
$17.2K ﹤0.01%
5,336
-2,790
-34% -$9.78K
WLDN icon
2115
Willdan Group
WLDN
$1.29B
$17.2K ﹤0.01%
622
VWE
2116
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$17.1K ﹤0.01%
+2,181
New +$20.1K
MBIN icon
2117
Merchants Bancorp
MBIN
$2.54B
$17.1K ﹤0.01%
756
HRTX icon
2118
Heron Therapeutics
HRTX
$63.5M
$17.1K ﹤0.01%
6,126
LFCR icon
2119
Lifecore Biomedical
LFCR
$179M
$17.1K ﹤0.01%
1,714
AMAL icon
2120
Amalgamated Financial
AMAL
$1.53B
$17.1K ﹤0.01%
862
PKE icon
2121
Park Aerospace
PKE
$811M
$17K ﹤0.01%
1,329
ALTO icon
2122
Alto Ingredients
ALTO
$326M
$16.9K ﹤0.01%
4,566
JANX icon
2123
Janux Therapeutics
JANX
$978M
$16.9K ﹤0.01%
1,382
AKRO
2124
DELISTED
Akero Therapeutics
AKRO
$16.8K ﹤0.01%
1,776
SRTA
2125
Strata Critical Medical Inc
SRTA
$528M
$16.7K ﹤0.01%
+3,754
New +$27.1K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.